Credit score: Unsplash/CC0 Public Area
A brand new scientific apply guideline developed by a activity pressure of the American Academy of Sleep Drugs supplies up to date suggestions for the remedy of central sleep apnea.
Accessible on-line as an accepted paper within the Journal of Scientific Sleep Drugs, the rule updates the AASM’s earlier apply parameters printed in 2012 and 2016. Amongst different important updates, it incorporates proof from current research of adaptive servo air flow and addresses new developments together with the introduction of transvenous phrenic nerve stimulation as a novel remedy.
“Central sleep apnea is a complex form of sleep-disordered breathing that requires individualized, patient-centered care,” stated lead writer Dr. M. Safwan Badr, chair of the AASM activity pressure and chair of the division of inner drugs at Wayne State College Faculty of Drugs in Detroit, Michigan. “It is essential for the treating clinician to prioritize improvements in quality of life and functional outcomes rather than focusing exclusively on the elimination of disordered breathing events.”
Central sleep apnea entails disruption of sleep attributable to an absence or discount in respiration effort coupled with a discount or cessation in airflow. This respiration instability can happen with numerous scientific circumstances together with coronary heart failure, obstructive sleep apnea, and use of opioids. The pathogenesis of central sleep apnea can fluctuate relying on the underlying scientific situation.
All 9 scientific suggestions within the guideline are designated as “conditional,” that means that they mirror a decrease diploma of certainty and require the clinician to make use of scientific judgment whereas contemplating the affected person’s values and preferences to find out the very best plan of action. These suggestions assist six remedy choices for particular etiologies of central sleep apnea: steady optimistic airway stress, bilevel optimistic airway stress with a backup price, adaptive servo air flow, low-flow oxygen, oral acetazolamide, and transvenous phrenic nerve stimulation. The rule states that clinicians should think about the underlying situation contributing to respiration instability when deciding on and optimizing remedy for central sleep apnea.
Adaptive servo air flow acquired a conditional advice for central sleep apnea attributable to a number of etiologies. Nevertheless, due to questions raised by one scientific trial involving sufferers with central sleep apnea and systolic coronary heart failure, the rule emphasizes that remedy with adaptive servo air flow in sufferers with coronary heart failure with decreased ejection fraction needs to be restricted to facilities with expertise and may embrace shut monitoring and follow-up.
The rule features a new conditional advice for transvenous phrenic nerve stimulation for major central sleep apnea and central sleep apnea attributable to coronary heart failure. This remedy entails the usage of an implantable gadget that activates mechanically and works repeatedly to watch and stabilize respiration. In 2017, the Meals and Drug Administration authorised the gadget to deal with reasonable to extreme central sleep apnea in grownup sufferers. As a result of the remedy requires an invasive process, shouldn’t be universally accessible, and is related to excessive prices, the rule advises that it might be extra applicable to contemplate different remedies first.
To develop the rule, the AASM commissioned a activity pressure of sleep drugs physicians with experience in treating central sleep apnea. They crafted scientific apply suggestions based mostly on a scientific overview of the literature and an evaluation of the proof in response to the GRADE course of, taking into account the knowledge of proof, useful and dangerous results, affected person values and preferences, and useful resource use. The draft guideline was posted for public remark, and the AASM board of administrators authorised the ultimate suggestions.
This guideline was endorsed by the Alliance of Sleep Apnea Companions, American Affiliation for Respiratory Care, American Affiliation of Sleep Technologists, Australasian Sleep Affiliation, European Respiratory Society, European Sleep Analysis Society, Coronary heart Failure Society of America, Society of Anesthesia and Sleep Drugs, and the Society of Behavioral Sleep Drugs. The American Academy of Otolaryngology-Head and Neck Surgical procedure and its basis affirmed the worth of this guideline.
The co-authors of the rule are Dr. Rami N. Khayat, Dr. J. Shirine Allam, Suzanne Hyer, Dr. Reem A. Mustafa, Dr. Matthew T. Naughton, Dr. Susheel Patil, Dr. Grace Pien, Dr. Winfried Randerath, and Dr. Christine Gained. GRADE methodologist Rebecca Morgan offered further help.
Extra data:
M. Safwan Badr et al, Therapy of central sleep apnea in adults: an American Academy of Sleep Drugs scientific apply guideline, Journal of Scientific Sleep Drugs (2025). DOI: 10.5664/jcsm.11858
View extra AASM scientific apply pointers and study extra in regards to the guideline growth course of.
Supplied by
American Academy of Sleep Drugs
Quotation:
New guideline supplies remedy suggestions for central sleep apnea (2025, October 27)
retrieved 27 October 2025
from https://medicalxpress.com/information/2025-10-guideline-treatment-central-apnea.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
